chrisvoncsefalvay/vaers-outcomes huggingface dataset:
started itching and itched like crazy all over her body on her shoulders and down her legs, on her buttocks, and all on her back/a little itch across her back; Felt real chilled and her skin felt like it had little goosebumps/chilled a lot/has been cold and really chillychills sometimes//chilly all over; Felt real chilled and her skin felt like it had little goosebumps/chilled a lot/has been cold and really chillychills sometimes//chilly all over; Felt real chilled and her skin felt like it had little goosebumps/chilled a lot/has been cold and really chillychills sometimes//chilly all over; This is a spontaneous report from a contactable consumer (who reported for herself). A 84-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot number EN62W) on 3Mar2021 at 1330 via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization, in left arm.  Historical vaccine included: bnt162b2 (COMIRNATY, Solution for injection, Lot number: EL926F) dose 1 on 10Feb2021 at 1330, as a single dose, for covid-19 immunization, in left arm and experienced Arm was just barely and Back was itching. Medical history included: Lupus (From: 2004 and Ongoing) the creatinine in her urine had gone up; too much calcium in her urine; fasciitis in her foot in January; cortisone shot in her foot on 12Jan2021; on 08Feb2021 she had another cortisone shot in her foot. Concomitant medications included: Vitamin D2 50mg once a week; They took her off of it before she had the Covid injection. On 04Mar2021, the patient started itching and itched like crazy all over her body, felt real chilled and her skin felt like it had little goosebumps. She took Benadryl just about every night, but it makes her so sleepy and puts her to sleep. Her doctor sent her some topical cream, but it took 2 tubes of cream to cover the itchy spot. She used some, but it didn't help her at all. The Benadryl (Diphenhydramine HCl; barcode: 30048284) 25mg was the only thing that stopped it. She took one. She would take one when she would get ready to go to bed. It puts her to sleep real easy. She spoke with his (her doctor) nurse and she explained to him what was happening. She hasn't visited him about this. He prescribed the topical cream Triamcinolone Acetonide ointment USP, 0.1% 15 grams. The clinical outcome of the event pruritis was not recovered; chills, feeling cold, and Goose bumps was recovering.   Information on lot/ batch number has been requested.
Vaginal bleeding, cramps and headaches as of 5/13/2021 to present day. Period cycle was prior to vaccination and only last 3 days.
side effects symptoms of the moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects symptoms of the moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects symptoms of the moderna vaccine). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (side effects symptoms of the moderna vaccine) outcome was unknown.            No concomitant medication was reported.
Red, swollen warm to the touch injection site a few hours after injection.  Following day, fever chills, myalgia, lymphadenopathy most of Right side of neck, axillary, groin ect.  Worse 48 hours post.  Swelling in 4th and 5th digit (recent surgery) all on right side.  Chest tightness, sinus tachycardia.
little sore arm for first dose//couldn't even raise arm, could not use arm for 1 to 2 weeks; little headache for first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little sore arm for first dose//couldn't even raise arm, could not use arm for 1 to 2 weeks) and HEADACHE (little headache for first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006821A) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer.   On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (little sore arm for first dose//couldn't even raise arm, could not use arm for 1 to 2 weeks) and HEADACHE (little headache for first dose). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (little sore arm for first dose//couldn't even raise arm, could not use arm for 1 to 2 weeks) and HEADACHE (little headache for first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications was provided by the reporter.
About 2~3 minutes after the vaccination, patient start to feel discomfort. Patient described the feeling as dizzy, nauseous, and sweating. Patient said she feel like she might vomit. Patient did appear to be in strong discomfort via visual observation, and sweat was seem from her forehead. Patient was under direct observation of pharmacist at the time; pharmacist encouraged her to stay seated on chair due to dizziness, and carried a conversation to ensure that patient is conscious. Patient said she did not feel there was any change in her breathing ability, but it did sound like she takes her breath more often. The onset of symptoms persisted for about 10 minutes, and then the patient reported that the symptoms have improved. After about 15 minutes, patient resumed what appear to be a normal state with most of the discomfort having gone away, and, after having checked with the pharmacy to acknowledge that she has now feel much better, left the store with a companion (probably a friend or family).  Patient said she has experienced this before from other blood-drawing events, but this did not happen during her first shot.
3rd Shot: I got another shot of Pfizer at 11 AM on 25Jul; Interchange of vaccine products; 3rd Shot: I got another shot of Pfizer at 11 AM on 25Jul; fever of 100.4 which lasted for about 24 hours; severe arm pain; fatigue; headache; heart raced (my resting rate is usually 50-60 BPM but it reached 70-80 after the shot)/Increased heart rate; heart raced (my resting rate is usually 50-60 BPM but it reached 70-80 after the shot)/Increased heart rate; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 25 year-old female patient received bnt162b2 (BNT162B2), administration date 25Jul2021 11:00 (Batch/Lot number: unknown) at the age of 25 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Sinopharm (1st dose, did not experience any side effects), administration date: 21Feb2021, when the patient was 25 years old, for COVID-19 immunization; Sinopharm (2nd dose, experienced arm pain, fatigue, and a hotter body (but my body temperature is normal), administration date: 11Mar2021, when the patient was 25 years old, for Covid-19 immunization; Sinopharm (2nd dose), for Covid-19 immunization, reaction(s): "fatigue", "hotter body", "arm pain". The following information was reported: OFF LABEL USE (non-serious), IMMUNISATION (non-serious) all with onset 25Jul2021 22:00, outcome "unknown" and all described as "3rd Shot: I got another shot of Pfizer at 11 AM on 25Jul"; INTERCHANGE OF VACCINE PRODUCTS (non-serious) with onset 25Jul2021 22:00, outcome "unknown", described as "Interchange of vaccine products"; PYREXIA (non-serious) with onset 25Jul2021 22:00, outcome "unknown", described as "fever of 100.4 which lasted for about 24 hours"; PAIN IN EXTREMITY (non-serious) with onset 25Jul2021 22:00, outcome "unknown", described as "severe arm pain"; FATIGUE (non-serious) with onset 25Jul2021 22:00, outcome "unknown", described as "fatigue"; HEADACHE (non-serious) with onset 25Jul2021 22:00, outcome "unknown", described as "headache"; PALPITATIONS (non-serious), HEART RATE INCREASED (non-serious) all with onset 25Jul2021 22:00, outcome "unknown" and all described as "heart raced (my resting rate is usually 50-60 BPM but it reached 70-80 after the shot)/Increased heart rate". Relevant laboratory tests and procedures are available in the appropriate section. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
itching that started @injection site and then spread across body, facial flushing Administered 50 mg of diphenhydramine orally and continued to observe Patient's husband was called and he took her home after approximately 30 mins.
This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 12-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 12-Feb-2022) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2022 at 11:45 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 12-Feb-2022 at 11:45 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 12-Feb-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 12-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 12-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 12-Feb-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant information was reported. The patient's Ethnicity reported as Black or African American. Patient allergies to medications, food and other products was unknown. Vaccination date was reported as 12 Feb 2022 11:45:19.The patient received booster dose. Its 30 days Expiry date vaccine went into 2 to 8 degree C thaw state on or about to 20-Dec-2021, this vaccine administered until its Mfg. expiry date of 04-Apr-2022. No treatment information was reported. This case was linked to MOD-2022-542869 (Patient Link).
swollen site; she experienced swollen site, red; severe itchiness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swollen site), VACCINATION SITE ERYTHEMA (she experienced swollen site, red) and PRURITUS (severe itchiness) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     The patient's past medical history included Arm fracture (Both of her arms have atrophied and she also has a fractured and dislocated right arm.) and Chemotherapy. Concurrent medical conditions included Drug allergy (Allergic to Phenergan, Bactrim, Flagyl, Benzomites PO), Allergy to antibiotic (Tetracycline), Iodine allergy, Adhesive tape allergy (IV site tape) and Autoimmune disorder. Concomitant products included HYDROXYZINE, HYDROMORPHONE HYDROCHLORIDE (DILAUDID), DIAZEPAM, Pepcid, BACLOFEN, ONDANSETRON (ZOFRAN [ONDANSETRON]), CLONIDINE, FLUTICASONE, TRIAMCINOLONE, LIDOCAINE, SALBUTAMOL (ALBUTEROL HFA), DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ITCH) and MUPIROCIN for an unknown indication, TRAZODONE.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-May-2021, the patient experienced VACCINATION SITE SWELLING (swollen site), VACCINATION SITE ERYTHEMA (she experienced swollen site, red) and PRURITUS (severe itchiness). At the time of the report, VACCINATION SITE SWELLING (swollen site), VACCINATION SITE ERYTHEMA (she experienced swollen site, red) and PRURITUS (severe itchiness) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment medications were provided   This case was linked to MOD-2021-260213 (Patient Link).
The day after receiving my over 65 flu shot my blood sugar was 420.  It continued to be in the 400 range for days, despite not eating and increasing insulin dosages.   This went on for 2 weeks.  This has never happened to me in 37 years of being a diabetic.  The doctor and I ruled out all other possibilities.  It had to have been the flu shot.
This case was reported by a other health professional via call center representative and described the occurrence of headache in a patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced headache and generalized pruritus. On an unknown date, the outcome of the headache and generalized pruritus were unknown. It was unknown if the reporter considered the headache and generalized pruritus to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The health care professional reported that the patient experienced an adverse reaction to the SHINGRIX vaccine including severe headache and severe systemic itching (per patient, every part of her body above her knees were affected). No other signs of an allergic reaction were identified.
3-12-08 TdaP given at well dx arm - patient a sx; 3-13-08 Onset chills, fever 102.0, vomiting, given Tylenol and Albuteral; 3-15-08 Right arm 4cm Traic erythema, tender; 3-17-08 Redness - increased redness, swelling much of right upper arm of vaccine site.  Decreased fever to 97.3, decreased BPI sx, still tired, achy.  Dx vaccine, prescribed Prednisone.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related injuries. On or about 30-JAN-2015, a pharmacist administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about October 2016, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13Sep2022 at 16:15 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 30 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Anti-viral details, Product=COVID 19 Treatment, Brand=Paxlovid, Treatment start date=14Dec2022, Treatment stop date=15Dec2022, Lot number=GF3597, Indication=Treatment of COVID-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Broke out in hives/rash covering head to waist including inner elbows. symptoms continued for approx. 10 days before fading. Took Sudafed and Benydrahl for symptoms.
Full body hives beginning 1/1 as well as sore and swollen breasts on both sides
Pt. states that after receiving the 2nd dose of Moderna 02/27/2021, started experiencing symptoms 02/28/2021 of fever, fatigue, and pain in the arm at the injection site. Primary visit 08/2021 for check up, no recommendations. Still experiencing symptoms.
Flu-like symptoms - nausea, sweat.  Arm sore immediately after injection - sore for 2 days.
Patient said ~4 to 6 hours after his first dose, both forearms became itchy, which lasted ~24 hr. There was no rash, and he had no known pre-existing health condition that would explain the itch. He will follow up with the Department of Health to determine eligibility for second dose.
Systemic: blood in urine-Medium, Additional Details: Patient called and stated she had Moderna booster the day before and now has blood in urine. could be possible side effect from vaccine, not sure. told her to contact her doctor and she said yes, she is calling her primary care provider after our phone call.
Four months after vaccine started having a thumping sound in my right ear. Would hear it intermittently and sometimes there would be a sharp pain.
Started feeling itchiness on the injection site on 3-14-21 (day 7 after the shot) off and on, but mostly off.  Nothing troublesome.  Today, morning of 3-17-21 (day 10 after shot), I felt a slightly stronger itch and noticed a slight pinkish rash at injection site about 3" long and  2" wide tapering at the top and bottom.  As the day continued, the stronger itchiness grew more frequent and rash slightly bigger and redder/more noticeable.  Finally had to put some hydrocortisone cream for some relief, but so far it's not really troublesome.  No pain thank goodness.  This happened to me before, 3 years ago, a week after I got my Shingrix vaccine shot (which had a much bigger, redder, raised rash).  When I read about the rashes happening to some people after the Moderna shot, the description was exactly like my post-Shingrix shot rash, but fortunately I had no pain, just itchiness, a little warm to the touch.  So, I was expecting that I'd probably get the rash and sure enough I have.  That's it so far with this current rash after my first dose of Moderna vaccine.  I treated the rash after the Shingrix  shot with just hydrocortisone cream occasionally (I don't recall having to resort to taking an antihistamine) and the rash and itchiness went away gradually after about 2-3 days. Obviously, I'm hoping the same thing will happen with this rash.
PATIENT WAS SEEN IN THE OFFICE BY HER HEALTHCARE PROVIDER WHOM CALLED ME AND TOLD ME THAT SHE STARTED WITH A ITCHY WIDESPREAD RASH ON NECK, SCALP AND ARM PITS. THE RASH WAS STARTING TO COME DOWN HER ARMS AS WELL WHEN SEEN. SHE GOT THE RASH A COUPLE OF DAYS AFTER THE VACCINATION AND DID NOT REPORT IT UNTIL HER APPOINTMENT ON 12/12/19. THE DOCTOR WAS NOT CLEAR IF IT WAS VACCINE RELATED OR NOT SO WE ARE REPORTING.
Pt stated on 12/17/09 office visit that 24 hours after receiving both GARDASIL and Influenza she developed swelling around (L) eye, included the upper lid, this resolved within 24 hours, no care was sought, no measures were taken for this, no MD was contacted.
L arm Tenderness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (L arm Tenderness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine and Multiple allergies (Unspecified). Concomitant products included OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for Gastrointestinal disorder, ALPRAZOLAM (XANAX), DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), VORTIOXETINE HYDROBROMIDE (TRINTELLIX) and BACLOFEN for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (L arm Tenderness). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE PAIN (L arm Tenderness) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Other concomitant medicines included Loinzeff for gastrointestinal issues and migraine medicines which were stopped on 03-FEB-2021 advised by HCP to take once a month.   This case was linked to MOD-2021-039177 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Jul-2021: Significant follow-up The event outcome was updated from unknown to recovered/resolved.
Same symptom as wife. Did not go to the doctor. Dizziness & loss of energy.
I was giving shots for a coworker the box i thought was hib was actually the bexsero, no reaction has come from the child and mother was made aware of incident. mother says she is doing well and will come back on the 9 month appointment to receive the HIB that was missed.
pt recvd vax;8 days later, elev liver enzymes, fever, n, noc sweats;to hosp;
extra exhaustion; Soreness at site of injection for two days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Lot number: EL3248) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "recovered", described as "Soreness at site of injection for two days"; FATIGUE (non-serious), outcome "unknown", described as "extra exhaustion".  Additional Information: Events took place after use of product.  No follow-up attempts are needed. No further information is expected.
The 15 year old female complained of being anxious. She was shaking almost like she was having a seizure for about 2 minutes. She felt better and went home with her dad.